Clinical Trial: Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT
Study Status: Completed
Recruit Status: RECRUITING
Condition: EBV Infection After Allogenic HSCT
Study Type: INTERVENTIONAL
Official Title: Multicenter, Open Label, Single-arm Exploratory Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT
Brief Summary:
This is a multi-center, single arm, open-label, phase I study to determine the safety and effectiveness of EBV-TCR-T cell immunotherapy in treating EBV virus infection after allogenic HSCT.
Read more